Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meera Sridharan

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Oncology (Williston Park, N.Y.)|April 8, 2014
Colorectal cancer: how emerging molecular understanding affects treatment decisionsMeera Sridharan, Joleen M Hubbard, Axel Grothey
Kidney International Reports|October 26, 2020
Complement in Secondary Thrombotic MicroangiopathyLilian Monteiro Pereira Palma, Meera Sridharan, Sanjeev Sethi
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 26, 2022
Clinical Utility and Potential Cost Savings of Pharmacologic Monitoring of Eculizumab for Complement-Mediated Thrombotic MicroangiopathyMeera Sridharan, Ronald S Go, Maria A V Willrich
Journal of Immunological Methods|July 23, 2018
Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and managementMeera Sridharan, Ronald S Go, Maria A V Willrich
Seminars in Thrombosis and Hemostasis|January 11, 2019
Factor V Deficiency with a Thrombotic Clinical PhenotypeMeera Sridharan, Lea M Coon, Dong Chen, et al.
The American Journal of Emergency Medicine|December 25, 2019
Real-world utilization of andexanet alfaCaitlin S Brown, Rachael A Scott, Meera Sridharan, et al.
The American Journal of Emergency Medicine|February 7, 2020
The authors reply: Still much to learn about andexxa alfa in the EDCaitlin S Brown, Rachael A Scott, Meera Sridharan, et al.
Frontiers in Immunology|January 30, 2026
Complement-mediated HUS revisited: evolving insights into pathophysiology, diagnosis, and treatmentRuah Alyamany, Ann M Moyer, Maria Alice V Willrich, et al.
European Journal of Haematology|June 29, 2019
Postsurgical thrombotic microangiopathy: Case series and review of the literatureMeera Sridharan, C Christopher Hook, Nelson Leung, et al.
The American Journal of the Medical Sciences|September 5, 2018
Shiga Toxin as a Potential Trigger of CFHR1 Deletion-Associated Thrombotic MicroangiopathySwarna Sri Nalluru, Meera Sridharan, Ronald S Go, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Oncology (Williston Park, N.Y.)|April 8, 2014
Colorectal cancer: how emerging molecular understanding affects treatment decisionsMeera Sridharan, Joleen M Hubbard, Axel Grothey
Kidney International Reports|October 26, 2020
Complement in Secondary Thrombotic MicroangiopathyLilian Monteiro Pereira Palma, Meera Sridharan, Sanjeev Sethi
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 26, 2022
Clinical Utility and Potential Cost Savings of Pharmacologic Monitoring of Eculizumab for Complement-Mediated Thrombotic MicroangiopathyMeera Sridharan, Ronald S Go, Maria A V Willrich
Journal of Immunological Methods|July 23, 2018
Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and managementMeera Sridharan, Ronald S Go, Maria A V Willrich
Seminars in Thrombosis and Hemostasis|January 11, 2019
Factor V Deficiency with a Thrombotic Clinical PhenotypeMeera Sridharan, Lea M Coon, Dong Chen, et al.
The American Journal of Emergency Medicine|December 25, 2019
Real-world utilization of andexanet alfaCaitlin S Brown, Rachael A Scott, Meera Sridharan, et al.
The American Journal of Emergency Medicine|February 7, 2020
The authors reply: Still much to learn about andexxa alfa in the EDCaitlin S Brown, Rachael A Scott, Meera Sridharan, et al.
Frontiers in Immunology|January 30, 2026
Complement-mediated HUS revisited: evolving insights into pathophysiology, diagnosis, and treatmentRuah Alyamany, Ann M Moyer, Maria Alice V Willrich, et al.
European Journal of Haematology|June 29, 2019
Postsurgical thrombotic microangiopathy: Case series and review of the literatureMeera Sridharan, C Christopher Hook, Nelson Leung, et al.
The American Journal of the Medical Sciences|September 5, 2018
Shiga Toxin as a Potential Trigger of CFHR1 Deletion-Associated Thrombotic MicroangiopathySwarna Sri Nalluru, Meera Sridharan, Ronald S Go, et al.
Pageof 6